Introduction Despite an increasing population of patients supported with a left ventricular
assist device (LVAD), it remains a complex therapy, and patients are frequently admitted …

Introduction: Ventricular assist devices (LVADs) are a valuable therapy for end-stage heart
failure patients. However, some adverse events still persist, such as suction that can trigger …

Objectives Six months after withdrawal of the HeartWare HVAD System (HVAD; Medtronic)
from sale, approximately 4000 patients continue ongoing support with this device. In light of …

Background The rising heart failure rates globally show the pressing demand for treatment
progress, especially in Left Ventricular Assist Devices (LVADs). Axial-flow pump LVADs are …

Simulators are expected to assume a prominent role in the process of design—development
and testing of cardiovascular medical devices. For this purpose, simulators should capture …

Background Dynamic respiratory maneuvers induce heterogenous changes to flow‐
pulsatility in continuous‐flow left ventricular assist device patients. We evaluated the …

Following the withdrawal of the HeartWare ventricular assist device (HVAD, Medtronic Inc.,
United States) from the global market, 1 the HeartMate3 (HM3, Abbott Laboratories, United …

Accurate activity classification is essential for the advancement of closed-loop control for left
ventricular assist devices (LVADs), as it provides necessary feedback to adapt device …

Continuous monitoring of left ventricular stroke work (LVSW) may improve the medical
management of patients with rotary left ventricular assist devices (LVAD). However …

This dissertation explores two critical aspects of decision-making under uncertainty:
continuous data monitoring in healthcare and the impact of AI interpretability on adoption …